Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients
- PMID: 1884891
- DOI: 10.1007/BF00418274
Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients
Abstract
Factors associated with diabetes onset were analysed for their predictive value in 708 first-degree relatives of Type 1 (insulin-dependent) diabetic patients including 374 parents and 308 siblings of Type 1 diabetic patients. Relatives were prospectively followed for 2,304 subject years with blood samples for specific autoantibody evaluation. Islet cell cytoplasmic autoantibody titres were quantified in Juvenile Diabetes Foundation units with a threshold of positivity of 5 units. Insulin autoantibodies were determined using Tyr-A14 iodinated human insulin. HLA typing was performed in 92% of the relatives. During the time of study, 17 of 646 (2.6%) relatives showed islet cell antibodies. During follow-up, eight relatives developed diabetes, including six with high islet cell antibody titre. Taking titres above 20 units increased the positive predictive value from 35% to 75% whereas the presence of insulin autoantibodies did not increase the positive predictive value for the disease. Analysis of metabolic profiles months before the onset of diabetes by either oral or intravenous glucose loads, indicated a considerable level of heterogeneity with relatives with a high islet cell antibody titre who rapidly developed insulin-dependent diabetes, whereas other remained insulin-independent during the same observation period despite comparable titres. This study clearly indicates that initial islet cell antibody titre is not sufficient to predict individual outcome. Follow-up samples are clearly needed to monitor progression of the disease. Few relatives with persistent immunologic positivity progress to clinical Type 1 diabetes, suggesting that non-progressive and sub-clinical Beta-cell dysfunction is common.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals.Diabetologia. 1992 Jun;35(6):570-6. doi: 10.1007/BF00400486. Diabetologia. 1992. PMID: 1612231
-
Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study.Diabetologia. 1988 Oct;31(10):741-6. doi: 10.1007/BF00274776. Diabetologia. 1988. PMID: 3071483
-
Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies.Diabetologia. 1991 Oct;34(10):727-33. doi: 10.1007/BF00401518. Diabetologia. 1991. PMID: 1959705
-
Predicting type I diabetes.Diabetes Care. 1990 Jul;13(7):762-5. doi: 10.2337/diacare.13.7.762. Diabetes Care. 1990. PMID: 2201499 Review.
-
Epidemiology of islet cell antibodies.Epidemiol Rev. 1989;11:182-203. doi: 10.1093/oxfordjournals.epirev.a036036. Epidemiol Rev. 1989. PMID: 2680555 Review.
Cited by
-
Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk.Diabetologia. 2012 Jul;55(7):1926-36. doi: 10.1007/s00125-012-2523-3. Epub 2012 Mar 23. Diabetologia. 2012. PMID: 22441569
-
Natural history of preclinical IDDM in high risk siblings. Childhood Diabetes in Finland Study Group.Diabetologia. 1994 Apr;37(4):388-93. doi: 10.1007/s001250050122. Diabetologia. 1994. PMID: 8063040
-
Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study.Diabetologia. 1992 Oct;35(10):951-7. doi: 10.1007/BF00401424. Diabetologia. 1992. PMID: 1451952
-
Islet cell antibodies in normal French schoolchildren.Diabetologia. 1992 Jun;35(6):577-82. doi: 10.1007/BF00400487. Diabetologia. 1992. PMID: 1612232
-
Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals.Diabetologia. 1992 Jun;35(6):570-6. doi: 10.1007/BF00400486. Diabetologia. 1992. PMID: 1612231
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials